<!– –>
Covid-19, a research by the Istituto Superiore di Sanità confirms that type I interferon can block the progression of the disease
A new weapon could arrive from Italy in the fight against Covid-19. Type I interferon (IFN), released by plasmacytoid dendritic cells (pDc) at the beginning of coronavirus infection, appears to elicit an immune response in the body that blocks the progression of the disease. The discovery comes from the joint work of a team of researchers (University of San Raffaele in Milan, Polyclinic of Tor Vergata, University of Padua, Metabolic Fitness Association) coordinated by the Istituto Superiore di Sanita ‘(ISS). The study published in Plos Pathogens analyzes precisely the mechanisms of innate immune responses in the pathogenesis of Covid-19.
Read Also
- How to improve your sleep quality May 27, 2021
- FDA Authorizes Pfizer Vaccine for Children 12-15 Years May 29, 2021
- Laura Spoya to those who question the inoculation against COVID-19: “Thanks to the vaccine I’m fine” Aug 16, 2021
- Heatwaves and Covid-19: Health authorities estimate the excess number of deaths in France this summer at 10,420 Nov 22, 2022
- Diet has an impact on inflammatory activity via intestinal bacteria Apr 13, 2021
- Covid, immunologist Clerici: “Dear Zangrillo, bulletins keep your guard up” Aug 12, 2021
- Ophthalmological exam: To evaluate the visual health of your children! Jun 5, 2022
